• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy in Early-Stage Invasive Breast Cancer.

作者信息

Blum Joanne L, Robert Nicholas, Andersen Jay, Favret Anne, Ward Patrick, Osborne Cynthia, Pippen John

机构信息

Joanne L. Blum, Texas Oncology, Baylor Sammons Cancer Center, US Oncology, Dallas, TX; Nicholas Robert, McKesson Specialty Health/US Oncology Network, The Woodlands, TX; Jay Andersen, Compass Oncology, US Oncology, Portland, OR; Anne Favret, Virginia Cancer Specialist, US Oncology, Fairfax, VA; Patrick Ward, US Oncology, Cincinnati, OH; and Cynthia Osborne and John Pippen, Texas Oncology, Baylor Sammons Cancer Center, US Oncology, Dallas, TX.

出版信息

J Clin Oncol. 2018 Feb 1;36(4):428-429. doi: 10.1200/JCO.2017.75.3756. Epub 2017 Dec 11.

DOI:10.1200/JCO.2017.75.3756
PMID:29227724
Abstract
摘要

相似文献

1
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy in Early-Stage Invasive Breast Cancer.利用生物标志物指导早期浸润性乳腺癌辅助全身治疗的决策
J Clin Oncol. 2018 Feb 1;36(4):428-429. doi: 10.1200/JCO.2017.75.3756. Epub 2017 Dec 11.
2
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Focused Update Guideline Summary.使用生物标志物指导早期浸润性乳腺癌女性辅助性全身治疗的决策：美国临床肿瘤学会临床实践重点更新指南摘要
J Oncol Pract. 2017 Nov;13(11):763-766. doi: 10.1200/JOP.2017.024646. Epub 2017 Jul 11.
3
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update.使用生物标志物指导早期浸润性乳腺癌女性辅助全身治疗决策：美国临床肿瘤学会临床实践指南重点更新
J Clin Oncol. 2017 Aug 20;35(24):2838-2847. doi: 10.1200/JCO.2017.74.0472. Epub 2017 Jul 10.
4
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Summary.使用生物标志物指导早期浸润性乳腺癌女性辅助性全身治疗的决策：美国临床肿瘤学会临床实践指南摘要
J Oncol Pract. 2016 Apr;12(4):384-9. doi: 10.1200/JOP.2016.010868. Epub 2016 Mar 8.
5
Recent ASCO Guideline on the Use of Biomarkers for Adjuvant Systemic Therapy in Early-Stage Invasive Breast Cancer.美国临床肿瘤学会（ASCO）近期关于早期浸润性乳腺癌辅助全身治疗生物标志物应用的指南。
J Clin Oncol. 2016 Nov 10;34(32):3943-3944. doi: 10.1200/JCO.2016.68.2385.
6
Optimal Adjuvant Chemotherapy Regimens for Patients With Early-Stage Breast Cancer.
J Clin Oncol. 2017 Apr 1;35(10):1137-1138. doi: 10.1200/JCO.2016.68.2393. Epub 2017 Jan 17.
7
Adjuvant endocrine therapy in premenopausal patients with hormone receptor-positive early breast cancer: Evidence evaluation and GRADE recommendations by the Italian Association of Medical Oncology (AIOM).绝经前激素受体阳性早期乳腺癌患者的辅助内分泌治疗：意大利肿瘤医学学会（AIOM）的证据评估和 GRADE 推荐。
Eur J Cancer. 2018 Aug;99:9-19. doi: 10.1016/j.ejca.2018.04.006. Epub 2018 Jun 7.
8
[Early-stage breast cancer - strategies for adjuvant systemic therapy].[早期乳腺癌——辅助性全身治疗策略]
Handchir Mikrochir Plast Chir. 2008 Aug;40(4):230-8. doi: 10.1055/s-2008-1038926. Epub 2008 Aug 20.
9
Treatment Patterns and Health Resource Utilization Among Patients Diagnosed With Early Stage Resected Non-Small Cell Lung Cancer at US Community Oncology Practices.美国社区肿瘤医疗实践中早期切除的非小细胞肺癌患者的治疗模式与卫生资源利用情况
Clin Lung Cancer. 2015 Nov;16(6):486-95. doi: 10.1016/j.cllc.2014.12.010. Epub 2014 Dec 31.
10
Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.利用雌激素受体信息在美国推广乳腺癌辅助多药化疗和他莫昔芬：1975 - 1999年
J Natl Cancer Inst Monogr. 2006(36):7-15. doi: 10.1093/jncimonographs/lgj003.